Computer-Assisted Design of Peptide-Based Radiotracers

In medical imaging, techniques such as magnetic resonance imaging, contrast-enhanced computerized tomography, positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are extensively available and routinely used for disease diagnosis. PET probes with peptide-based t...

Full description

Bibliographic Details
Main Authors: Vincenzo Patamia, Chiara Zagni, Ilaria Brullo, Erika Saccullo, Alessandro Coco, Giuseppe Floresta, Antonio Rescifina
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/7/6856
_version_ 1797607625229074432
author Vincenzo Patamia
Chiara Zagni
Ilaria Brullo
Erika Saccullo
Alessandro Coco
Giuseppe Floresta
Antonio Rescifina
author_facet Vincenzo Patamia
Chiara Zagni
Ilaria Brullo
Erika Saccullo
Alessandro Coco
Giuseppe Floresta
Antonio Rescifina
author_sort Vincenzo Patamia
collection DOAJ
description In medical imaging, techniques such as magnetic resonance imaging, contrast-enhanced computerized tomography, positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are extensively available and routinely used for disease diagnosis. PET probes with peptide-based targeting are typically composed of small peptides especially developed to have high affinity and specificity for a range of cellular and tissue targets. These probes’ key benefits include being less expensive than traditional antibody-based PET tracers and having an effective chemical modification process that allows them to be radiolabeled with almost any radionuclide, making them highly appealing for clinical usage. Currently, as with every pharmaceutical design, the use of in silico strategies is steadily growing in this field, even though it is not part of the standard toolkit used during radiopharmaceutical design. This review describes the recent applications of computational design approaches in the design of novel peptide-based radiopharmaceuticals.
first_indexed 2024-03-11T05:33:27Z
format Article
id doaj.art-1a32712b230543a88a2372c0fe82d391
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T05:33:27Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-1a32712b230543a88a2372c0fe82d3912023-11-17T16:57:02ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-04-01247685610.3390/ijms24076856Computer-Assisted Design of Peptide-Based RadiotracersVincenzo Patamia0Chiara Zagni1Ilaria Brullo2Erika Saccullo3Alessandro Coco4Giuseppe Floresta5Antonio Rescifina6Dipartimento di Scienze del Farmaco e della Salute, Università di Catania, Viale A. Doria 6, 95125 Catania, ItalyDipartimento di Scienze del Farmaco e della Salute, Università di Catania, Viale A. Doria 6, 95125 Catania, ItalyDipartimento di Scienze del Farmaco e della Salute, Università di Catania, Viale A. Doria 6, 95125 Catania, ItalyDipartimento di Scienze del Farmaco e della Salute, Università di Catania, Viale A. Doria 6, 95125 Catania, ItalyDipartimento di Scienze del Farmaco e della Salute, Università di Catania, Viale A. Doria 6, 95125 Catania, ItalyDipartimento di Scienze del Farmaco e della Salute, Università di Catania, Viale A. Doria 6, 95125 Catania, ItalyDipartimento di Scienze del Farmaco e della Salute, Università di Catania, Viale A. Doria 6, 95125 Catania, ItalyIn medical imaging, techniques such as magnetic resonance imaging, contrast-enhanced computerized tomography, positron emission tomography (PET), and single-photon emission computed tomography (SPECT) are extensively available and routinely used for disease diagnosis. PET probes with peptide-based targeting are typically composed of small peptides especially developed to have high affinity and specificity for a range of cellular and tissue targets. These probes’ key benefits include being less expensive than traditional antibody-based PET tracers and having an effective chemical modification process that allows them to be radiolabeled with almost any radionuclide, making them highly appealing for clinical usage. Currently, as with every pharmaceutical design, the use of in silico strategies is steadily growing in this field, even though it is not part of the standard toolkit used during radiopharmaceutical design. This review describes the recent applications of computational design approaches in the design of novel peptide-based radiopharmaceuticals.https://www.mdpi.com/1422-0067/24/7/6856imagingnuclear medicinepeptide probescomputer-assisted molecular designCADD
spellingShingle Vincenzo Patamia
Chiara Zagni
Ilaria Brullo
Erika Saccullo
Alessandro Coco
Giuseppe Floresta
Antonio Rescifina
Computer-Assisted Design of Peptide-Based Radiotracers
International Journal of Molecular Sciences
imaging
nuclear medicine
peptide probes
computer-assisted molecular design
CADD
title Computer-Assisted Design of Peptide-Based Radiotracers
title_full Computer-Assisted Design of Peptide-Based Radiotracers
title_fullStr Computer-Assisted Design of Peptide-Based Radiotracers
title_full_unstemmed Computer-Assisted Design of Peptide-Based Radiotracers
title_short Computer-Assisted Design of Peptide-Based Radiotracers
title_sort computer assisted design of peptide based radiotracers
topic imaging
nuclear medicine
peptide probes
computer-assisted molecular design
CADD
url https://www.mdpi.com/1422-0067/24/7/6856
work_keys_str_mv AT vincenzopatamia computerassisteddesignofpeptidebasedradiotracers
AT chiarazagni computerassisteddesignofpeptidebasedradiotracers
AT ilariabrullo computerassisteddesignofpeptidebasedradiotracers
AT erikasaccullo computerassisteddesignofpeptidebasedradiotracers
AT alessandrococo computerassisteddesignofpeptidebasedradiotracers
AT giuseppefloresta computerassisteddesignofpeptidebasedradiotracers
AT antoniorescifina computerassisteddesignofpeptidebasedradiotracers